Remove 2012 Remove 2017 Remove Medical director
article thumbnail

Tapestry Hospice Execs Settle Fraud Case for $1.4M; Prison Term, $3M Penalty in Angel Care Case

Hospice News

Dr. David Lovell, its founder and owner, launched the for-profit hospice in 2010, and the enterprise became Medicare-certified in 2012. Tapestry Hospice allegedly paid medical directors to “induce them to refer patients” to their organization in exchange for monthly stipends and signing bonuses for medical directors.

article thumbnail

New CMOs for Hospice of the Chesapeake, Care Synergy; HopeWest Taps New VP

Hospice News

Hospice of the Chesapeake Appoints New CMO Maryland-based Hospice of the Chesapeake recently named Dr. Marny Fetzer as its new chief medical officer. Fetzer is currently system medical director for palliative care and hospice services at Illinois-based Ascension Health. He was previously medical director at Compassus since 2017.

Hospice 246
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Blue Monarch CEO: Hospice Startup Seeks to Raise Bar on Quality

Hospice News

I became a registered nurse in 2012 and received my nurse practitioner degree in 2017. We also have a home health aide, a chaplain, a social worker, a patient intake coordinator and a medical director. As a nurse practitioner, what led you to begin a hospice program? Luckily, we have been able to stay fully staffed.

Hospice 264
article thumbnail

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Pallimed

By 2007, the Washington State Agency Medical Directors Group (AMDG), which included several eventual PROP members (23), published an “Interagency Guideline on Opioid Dosing for Chronic Non-Cancer Pain (26) that introduced the concept of hard dosing thresholds for opioid analgesics, which was later incorporated into the 2016 Guideline (2, 3).

2016 145
article thumbnail

Roger Chou’s Undisclosed Conflicts of Interest: How the CDC’s 2016 Guideline for Prescribing Opioids for Chronic Pain Lost Its Clinical and Professional Integrity

Pallimed

Chou had originally announced his intention to help influence opioid policy in a 2011 article that he co-authored with PROP’s founders (5), and he was a bold signatory to PROP’s 2012 Petition to the Food and Drug Administration (FDA) to change opioid labeling (6; See Figures 1a and 1b: First page and signatory page.)

2016 89